Electronic Health Records for Drug Repurposing: Current Status, Challenges, and Future Directions
Author:
Affiliation:
1. School of Biomedical Informatics The University of Texas Health Science Center at Houston Houston Texas USA
2. Department of Biostatistics Vanderbilt University Medical Center Nashville Tennessee USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1769
Reference10 articles.
1. Diagnosing the decline in pharmaceutical R&D efficiency
2. Drug repurposing: progress, challenges and recommendations
3. The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development
4. Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration
5. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer;Frontiers in Pharmacology;2023-08-10
2. Graphical Learning and Causal Inference for Drug Repurposing;2023-08-02
3. Risk of antidepressant initiation among users of cardiovascular agents and metformin.;Pharmacology Research & Perspectives;2023-04
4. Drug repurposing using real-world data;Drug Discovery Today;2023-01
5. Trailblazing Contemporary Frameworks for Drug Repurposing: A Saga on Drugs’ Expedition to Disinter the Veiled Destiny;Drugs and a Methodological Compendium;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3